481 related articles for article (PubMed ID: 23898077)
1. Circulating long non-coding RNAs in plasma of patients with gastric cancer.
Arita T; Ichikawa D; Konishi H; Komatsu S; Shiozaki A; Shoda K; Kawaguchi T; Hirajima S; Nagata H; Kubota T; Fujiwara H; Okamoto K; Otsuji E
Anticancer Res; 2013 Aug; 33(8):3185-93. PubMed ID: 23898077
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNAs: a new frontier in the study of human diseases.
Shi X; Sun M; Liu H; Yao Y; Song Y
Cancer Lett; 2013 Oct; 339(2):159-66. PubMed ID: 23791884
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer.
Ren S; Wang F; Shen J; Sun Y; Xu W; Lu J; Wei M; Xu C; Wu C; Zhang Z; Gao X; Liu Z; Hou J; Huang J; Sun Y
Eur J Cancer; 2013 Sep; 49(13):2949-59. PubMed ID: 23726266
[TBL] [Abstract][Full Text] [Related]
4. Targeting long non-coding RNAs in cancers: progress and prospects.
Li CH; Chen Y
Int J Biochem Cell Biol; 2013 Aug; 45(8):1895-910. PubMed ID: 23748105
[TBL] [Abstract][Full Text] [Related]
5. Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer.
Zhou X; Yin C; Dang Y; Ye F; Zhang G
Sci Rep; 2015 Jun; 5():11516. PubMed ID: 26096073
[TBL] [Abstract][Full Text] [Related]
6. The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer.
Ke D; Li H; Zhang Y; An Y; Fu H; Fang X; Zheng X
Oncotarget; 2017 Mar; 8(13):21516-21525. PubMed ID: 28423525
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNAs in plasma of patients with gastric cancers.
Tsujiura M; Ichikawa D; Komatsu S; Shiozaki A; Takeshita H; Kosuga T; Konishi H; Morimura R; Deguchi K; Fujiwara H; Okamoto K; Otsuji E
Br J Cancer; 2010 Mar; 102(7):1174-9. PubMed ID: 20234369
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.
Huang YK; Yu JC
World J Gastroenterol; 2015 Sep; 21(34):9863-86. PubMed ID: 26379393
[TBL] [Abstract][Full Text] [Related]
9. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells.
Yang F; Bi J; Xue X; Zheng L; Zhi K; Hua J; Fang G
FEBS J; 2012 Sep; 279(17):3159-65. PubMed ID: 22776265
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide long non-coding RNAs identified a panel of novel plasma biomarkers for gastric cancer diagnosis.
Zheng R; Liang J; Lu J; Li S; Zhang G; Wang X; Liu M; Wang W; Chu H; Tao G; Zhao Q; Wang M; Du M; Qiang F; Zhang Z
Gastric Cancer; 2019 Jul; 22(4):731-741. PubMed ID: 30603909
[TBL] [Abstract][Full Text] [Related]
11. Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer.
Li Q; Shao Y; Zhang X; Zheng T; Miao M; Qin L; Wang B; Ye G; Xiao B; Guo J
Tumour Biol; 2015 Mar; 36(3):2007-12. PubMed ID: 25391424
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Role of Circulating Long Non-Coding RNA H19 as a Promising Novel Biomarker in Plasma of Patients with Gastric Cancer.
Hashad D; Elbanna A; Ibrahim A; Khedr G
J Clin Lab Anal; 2016 Nov; 30(6):1100-1105. PubMed ID: 27184562
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of long noncoding RNAs on gastric cancer.
Li T; Mo X; Fu L; Xiao B; Guo J
Oncotarget; 2016 Feb; 7(8):8601-12. PubMed ID: 26788991
[TBL] [Abstract][Full Text] [Related]
14. Circulating CUDR, LSINCT-5 and PTENP1 long noncoding RNAs in sera distinguish patients with gastric cancer from healthy controls.
Dong L; Qi P; Xu MD; Ni SJ; Huang D; Xu QH; Weng WW; Tan C; Sheng WQ; Zhou XY; Du X
Int J Cancer; 2015 Sep; 137(5):1128-35. PubMed ID: 25694351
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis of long non-coding RNAs and mRNA expression profiles reveals the potential role of lncRNAs in gastric cancer pathogenesis.
Lin XC; Zhu Y; Chen WB; Lin LW; Chen DH; Huang JR; Pan K; Lin Y; Wu BT; Dai Y; Tu ZG
Int J Oncol; 2014 Aug; 45(2):619-28. PubMed ID: 24819045
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA UCA1 may be a novel diagnostic and predictive biomarker in plasma for early gastric cancer.
Gao J; Cao R; Mu H
Int J Clin Exp Pathol; 2015; 8(10):12936-42. PubMed ID: 26722487
[TBL] [Abstract][Full Text] [Related]
17. Circulating cell-free mRNA in plasma as a tumor marker for patients with primary and recurrent gastric cancer.
Tani N; Ichikawa D; Ikoma D; Tomita H; Sai S; Ikoma H; Okamoto K; Ochiai T; Ueda Y; Otsuji E; Yamagishi H; Miura N; Shiota G
Anticancer Res; 2007; 27(2):1207-12. PubMed ID: 17465264
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNAs: novel insights into gastric cancer.
Fang XY; Pan HF; Leng RX; Ye DQ
Cancer Lett; 2015 Jan; 356(2 Pt B):357-66. PubMed ID: 25444905
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of long noncoding RNAs in gastric cancer: a meta-analysis.
Gao S; Zhao ZY; Wu R; Zhang Y; Zhang ZY
Onco Targets Ther; 2018; 11():4877-4891. PubMed ID: 30147339
[TBL] [Abstract][Full Text] [Related]
20. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
